Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

(18)F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer

Trial Profile

(18)F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer

Phase of Trial: Phase II

Latest Information Update: 16 Sep 2018

At a glance

  • Drugs 18F DCFPyL (Primary)
  • Indications Adenocarcinoma; Prostate cancer
  • Focus Diagnostic use
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 30 Aug 2018 Planned primary completion date changed from 1 Jan 2019 to 1 Oct 2020.
    • 03 Aug 2017 Planned initiation date changed from 8 Aug 2017 to 9 Aug 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top